Immune durability and protection against SARS-CoV-2 re-infection in Syrian hamsters.
SARS-CoV-2
antibodies
hamster
immunity
re-infection
Journal
Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
pubmed:
26
3
2022
medline:
21
4
2022
entrez:
25
3
2022
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused a pandemic. As immunity to endemic human coronaviruses (i.e. NL63 or OC43) wanes leading to re-infection, it was unknown if SARS-CoV-2 immunity would also decline permitting repeat infections. Recent case reports confirm previously infected individuals can become re-infected; however, re-infection may be due to heterogeneity in the initial infection or the host immune response, or may be the result of infection with a variant strain that escapes pre-existing immunity. To control these variables, we utilized the Syrian hamster model to evaluate the duration of immunity and susceptibility to re-infection with SARS-CoV-2. Hamsters were given a primary mock or SARS-CoV-2 infection (culture media or 10
Identifiants
pubmed: 35333692
doi: 10.1080/22221751.2022.2058419
pmc: PMC9037228
doi:
Substances chimiques
Antibodies, Neutralizing
0
Antibodies, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1103-1114Subventions
Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Références
JAMA Intern Med. 2021 Oct 1;181(10):1407-1408
pubmed: 34048531
Lancet Infect Dis. 2021 Jan;21(1):52-58
pubmed: 33058797
Genome Med. 2020 Jul 28;12(1):68
pubmed: 32723359
Emerg Microbes Infect. 2020 Dec;9(1):2673-2684
pubmed: 33251966
Cell. 2021 Jan 7;184(1):169-183.e17
pubmed: 33296701
Virol J. 2017 Nov 22;14(1):230
pubmed: 29166910
Emerg Microbes Infect. 2021 Dec;10(1):797-809
pubmed: 33825619
J Gen Virol. 2020 Nov;101(11):1156-1169
pubmed: 32821033
Viruses. 2020 Jul 20;12(7):
pubmed: 32698441
Nature. 2021 Jul;595(7867):421-425
pubmed: 34030176
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
PLoS One. 2018 Jan 29;13(1):e0191789
pubmed: 29377913
J Virol. 2021 Jun 10;95(13):e0223220
pubmed: 33827954
Cell. 2020 Dec 10;183(6):1496-1507.e16
pubmed: 33171099
Emerg Microbes Infect. 2021 Dec;10(1):1284-1292
pubmed: 34120579
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
mBio. 2021 Aug 31;12(4):e0097421
pubmed: 34253053
Cell Rep Med. 2021 Jul 20;2(7):100354
pubmed: 34250512
Clin Infect Dis. 2020 Dec 3;71(9):2428-2446
pubmed: 32215622
Nat Microbiol. 2020 Dec;5(12):1598-1607
pubmed: 33106674
J Clin Microbiol. 2010 Aug;48(8):2940-7
pubmed: 20554810
Nature. 2020 Jul;583(7818):834-838
pubmed: 32408338
Lancet. 2021 Apr 17;397(10283):1459-1469
pubmed: 33844963
Sci Immunol. 2021 Dec 17;6(66):eabm3131
pubmed: 34699266
Proc Natl Acad Sci U S A. 2020 Jul 14;117(28):16587-16595
pubmed: 32571934
Clin Med (Lond). 2021 Jan;21(1):e52-e53
pubmed: 33303623
Science. 2020 Dec 4;370(6521):1227-1230
pubmed: 33115920
Science. 2021 Feb 5;371(6529):
pubmed: 33408181
J Med Virol. 2020 May;92(5):512-517
pubmed: 32073157
EClinicalMedicine. 2021 May;35:100861
pubmed: 33937733
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
EClinicalMedicine. 2021 Jun;36:100902
pubmed: 34056568
Pathogens. 2021 Jun 30;10(7):
pubmed: 34209230